The Maximum Allowable Cost program--some marketing consequences.
D003365:Costs and Cost Analysis; D005252:Fees, Pharmaceutical / Q000331:legislation & jurisprudence*; D005380:Financing, Government / Q000331:legislation & jurisprudence*; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration